Progress in cardiovascular diseases最新文献

筛选
英文 中文
Evolving paradigms in mechanical circulatory support and heart transplantation. 机械循环支持和心脏移植的发展模式。
IF 7.6
Progress in cardiovascular diseases Pub Date : 2026-11-10 DOI: 10.1016/j.pcad.2026.11.002
Aliya Izumi, David M Dudzinski, Ali Fatehi Hassanabad
{"title":"Evolving paradigms in mechanical circulatory support and heart transplantation.","authors":"Aliya Izumi, David M Dudzinski, Ali Fatehi Hassanabad","doi":"10.1016/j.pcad.2026.11.002","DOIUrl":"10.1016/j.pcad.2026.11.002","url":null,"abstract":"<p><p>Advanced heart failure management is increasingly defined by the interactions between evolving donor utilization and preservation strategies, mechanical circulatory support (MCS) technologies, and organ allocation frameworks. Heart donation after circulatory death has significantly expanded transplant availability in recent years, while advances in allograft preservation and ex vivo perfusion continue to challenge traditional constraints on ischemic time and donor selection. At the same time, modern temporary MCS platforms have demonstrated the feasibility of more prolonged support, enabling greater utilization of direct bridge-to-transplant pathways within allocation systems that prioritize temporary over durable support. Meanwhile, improvements in durable left ventricular assist device (LVAD) technology have progressively shifted their utilization toward destination therapy. Amid this dynamic therapeutic landscape, we sought to review current trends in donor utilization, preservation, mechanical support, and organ allocation. In doing so, we also evaluate how their intersection is reshaping contemporary treatment algorithms, resource stewardship, and pathways toward definitive heart replacement therapy.</p>","PeriodicalId":94178,"journal":{"name":"Progress in cardiovascular diseases","volume":" ","pages":""},"PeriodicalIF":7.6,"publicationDate":"2026-11-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149389168","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Integrating polygenic and classical risk factors for cardiovascular risk stratification in a polish primary-care cohort. 在波兰初级保健队列中整合心血管危险分层的多基因和经典危险因素。
IF 7.6
Progress in cardiovascular diseases Pub Date : 2026-11-07 DOI: 10.1016/j.pcad.2026.11.006
Maciej Banach, Przemyslaw Stempor, Tadeusz Osadnik, Agnieszka Gach, Dominik Strapagiel, Marcin Słomka, Milena Skóra, Martyna Fronczek, Mateusz Lejawa, Anna Goc, Ewa Boniewska-Bernacka, Anna Pańczyszyn, Gregory Y H Lip, Dimitri P Mikhailidis, Peter P Toth, Peter E Penson, Margus Viigimaa, Jacek Jóźwiak
{"title":"Integrating polygenic and classical risk factors for cardiovascular risk stratification in a polish primary-care cohort.","authors":"Maciej Banach, Przemyslaw Stempor, Tadeusz Osadnik, Agnieszka Gach, Dominik Strapagiel, Marcin Słomka, Milena Skóra, Martyna Fronczek, Mateusz Lejawa, Anna Goc, Ewa Boniewska-Bernacka, Anna Pańczyszyn, Gregory Y H Lip, Dimitri P Mikhailidis, Peter P Toth, Peter E Penson, Margus Viigimaa, Jacek Jóźwiak","doi":"10.1016/j.pcad.2026.11.006","DOIUrl":"https://doi.org/10.1016/j.pcad.2026.11.006","url":null,"abstract":"<p><strong>Background: </strong>Polygenic risk scores (PRS) promise improved cardiovascular risk stratification, but most validation derives from UK or Nordic biobanks. The transferability of these scores to Central European populations and their incremental value over classical risk factors in routine care remain unestablished.</p><p><strong>Objectives: </strong>To determine whether a coronary PRS derived from external European data transfers to a Polish primary-care population and adds discrimination for prevalent cardiovascular disease beyond classical risk factors.</p><p><strong>Methods: </strong>In the nationwide Polish LIPIDOGEN2015 primary-care cohort, we derived PRS for coronary heart disease, myocardial infarction (MI) and stroke from FinnGen data with continuous shrinkage priors and applied them to imputed genotypes. We compared allele frequencies of 1397 unrelated participants with a non-Finnish European (NFE) reference and, in 1328 participants with clinical data, related the PRS to coronary artery disease (CAD), MI and stroke recorded at baseline and to a composite including death during follow-up, with and without classical risk factors or SCORE2.</p><p><strong>Results: </strong>Allele frequencies correlated with the NFE reference (r = 0.97). Per standard deviation (SD), the coronary PRS was associated with prevalent CAD (odds ratio 1.36, 95% CI 1.11 to 1.67) and the composite endpoint (1.26, 95% CI 1.04 to 1.51), as were two validated genome-wide scores. Adding it to classical risk factors changed the area under the curve (AUC) for the composite endpoint by 0.0017 (95% CI -0.0005 to 0.0076), from 0.860 to 0.861; results with SCORE2 were similar. The study had 80% power for odds ratios per SD of 1.31 (CAD) and 1.27 (composite).</p><p><strong>Conclusions: </strong>A coronary PRS derived from external European data retains its association with prevalent CAD without re-derivation in this Polish primary-care cohort but, in this cross-sectional, event-limited sample, adds little discrimination to classical risk factors. Its value for predicting future events in this setting remains to be tested against incident outcomes.</p>","PeriodicalId":94178,"journal":{"name":"Progress in cardiovascular diseases","volume":" ","pages":""},"PeriodicalIF":7.6,"publicationDate":"2026-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149382450","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Beyond binary diagnoses: Rethinking cardiovascular risk across the continuum. 超越二元诊断:重新思考心血管风险的连续性。
IF 7.6
Progress in cardiovascular diseases Pub Date : 2026-11-06 DOI: 10.1016/j.pcad.2026.11.004
Leandro Slipczuk
{"title":"Beyond binary diagnoses: Rethinking cardiovascular risk across the continuum.","authors":"Leandro Slipczuk","doi":"10.1016/j.pcad.2026.11.004","DOIUrl":"https://doi.org/10.1016/j.pcad.2026.11.004","url":null,"abstract":"","PeriodicalId":94178,"journal":{"name":"Progress in cardiovascular diseases","volume":" ","pages":""},"PeriodicalIF":7.6,"publicationDate":"2026-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149358549","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Coronary physiology and the choice of revascularisation strategy. 冠状动脉生理学和血运重建策略的选择。
IF 7.6
Progress in cardiovascular diseases Pub Date : 2026-11-05 DOI: 10.1016/j.pcad.2026.11.001
Milan Milojevic, Luca Koechlin, Omer Dzemali
{"title":"Coronary physiology and the choice of revascularisation strategy.","authors":"Milan Milojevic, Luca Koechlin, Omer Dzemali","doi":"10.1016/j.pcad.2026.11.001","DOIUrl":"10.1016/j.pcad.2026.11.001","url":null,"abstract":"","PeriodicalId":94178,"journal":{"name":"Progress in cardiovascular diseases","volume":" ","pages":""},"PeriodicalIF":7.6,"publicationDate":"2026-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149345292","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Beyond edge-to-edge repair for the percutaneous treatment of mitral valve disease. 经皮治疗二尖瓣病变的超边缘修复。
IF 7.6
Progress in cardiovascular diseases Pub Date : 2026-11-05 DOI: 10.1016/j.pcad.2026.11.003
Filippo Pensotti, Ignacio J Amat-Santos
{"title":"Beyond edge-to-edge repair for the percutaneous treatment of mitral valve disease.","authors":"Filippo Pensotti, Ignacio J Amat-Santos","doi":"10.1016/j.pcad.2026.11.003","DOIUrl":"10.1016/j.pcad.2026.11.003","url":null,"abstract":"<p><p>Mitral regurgitation (MR) is one of the most prevalent valvular heart diseases worldwide. Mitral transcatheter edge-to-edge repair (M-TEER) has become the cornerstone percutaneous treatment for both primary and secondary MR; however, its efficacy remains highly anatomy-dependent, with a substantial proportion of patients deemed unsuitable and others experiencing residual or recurrent MR at follow-up. Looking beyond M-TEER, a growing armamentarium of alternative transcatheter strategies has emerged, including transcatheter mitral valve replacement (TMVR) platforms direct and indirect annuloplasty systems, and, more recently, percutaneous chordal replacement/leaflet-based technologies. This review discusses the current evidence supporting TMVR, transcatheter annuloplasty, and emerging leaflet-based strategies, focusing on those technologies most likely to redefine the treatment algorithm for mitral regurgitation over the coming years.</p>","PeriodicalId":94178,"journal":{"name":"Progress in cardiovascular diseases","volume":" ","pages":""},"PeriodicalIF":7.6,"publicationDate":"2026-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149345291","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Achilles heel of successful treatment of acute myocardial infarction: Tackling large thrombus burden and no reflow. 成功治疗急性心肌梗死的致命弱点:处理大血栓负担和无血流。
IF 7.6
Progress in cardiovascular diseases Pub Date : 2026-11-05 DOI: 10.1016/j.pcad.2026.10.011
Ting-Yu Wang, Tiffany Ho, Jinnette Dawn Abbott
{"title":"The Achilles heel of successful treatment of acute myocardial infarction: Tackling large thrombus burden and no reflow.","authors":"Ting-Yu Wang, Tiffany Ho, Jinnette Dawn Abbott","doi":"10.1016/j.pcad.2026.10.011","DOIUrl":"10.1016/j.pcad.2026.10.011","url":null,"abstract":"<p><p>Primary percutaneous coronary intervention (PCI) is the preferred reperfusion strategy for ST-segment elevation myocardial infarction (STEMI), rapidly restoring coronary blood flow, limiting infarct size, improving survival, and reducing recurrent ischemic events. Advances in interventional techniques and adjunctive therapies have enhanced its safety and efficacy over time, with high rates of successful epicardial reperfusion, however large intracoronary thrombus burden remains a major challenge during primary PCI. Extensive thrombus promotes distal embolization of platelet-fibrin aggregates and atherothrombotic debris, which mechanically occlude the downstream capillary bed during reperfusion triggering microvascular obstruction, inflammation, endothelial dysfunction, and the no-reflow phenomenon. Consequently, restoration of epicardial patency does not always translate into effective myocardial tissue perfusion or myocardial salvage, resulting in larger infarcts and worse clinical outcomes. Contemporary management strategies aim to reduce thrombus burden, preserve microvascular integrity, and improve myocardial salvage through adjunctive pharmacologic therapies, selective mechanical interventions, and optimized procedural techniques. Although routine use of aspiration thrombectomy and many adjunctive intracoronary therapies have not consistently improved clinical outcomes, selective use in carefully chosen patients remains an important component of contemporary practice. Emerging strategies are shifting the focus beyond restoration of epicardial flow toward preservation of the coronary microcirculation. Advances in intracoronary imaging, precision PCI, and therapies targeting inflammation, reperfusion injury, and microvascular dysfunction offer promising opportunities to individualize treatment and further improve outcomes in patients with STEMI and large thrombus burden.</p>","PeriodicalId":94178,"journal":{"name":"Progress in cardiovascular diseases","volume":" ","pages":""},"PeriodicalIF":7.6,"publicationDate":"2026-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149345293","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
What we know from Lp(a)HORIZON and what remains unknown. 我们从Lp(a)HORIZON了解到的和未知的。
IF 7.6
Progress in cardiovascular diseases Pub Date : 2026-11-05 DOI: 10.1016/j.pcad.2026.11.005
Ahmed Abdelaziz, Leandro Slipczuk, Deepak L Bhatt
{"title":"What we know from Lp(a)HORIZON and what remains unknown.","authors":"Ahmed Abdelaziz, Leandro Slipczuk, Deepak L Bhatt","doi":"10.1016/j.pcad.2026.11.005","DOIUrl":"https://doi.org/10.1016/j.pcad.2026.11.005","url":null,"abstract":"","PeriodicalId":94178,"journal":{"name":"Progress in cardiovascular diseases","volume":" ","pages":""},"PeriodicalIF":7.6,"publicationDate":"2026-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149345294","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Conduction system pacing as a primary strategy for cardiac resynchronization therapy: what is still missing? 传导系统起搏作为心脏再同步化治疗的主要策略:还缺少什么?
IF 7.6
Progress in cardiovascular diseases Pub Date : 2026-11-03 DOI: 10.1016/j.pcad.2026.10.014
Francesco Zanon, Lina Marcantoni, Francesco Fugetto
{"title":"Conduction system pacing as a primary strategy for cardiac resynchronization therapy: what is still missing?","authors":"Francesco Zanon, Lina Marcantoni, Francesco Fugetto","doi":"10.1016/j.pcad.2026.10.014","DOIUrl":"https://doi.org/10.1016/j.pcad.2026.10.014","url":null,"abstract":"","PeriodicalId":94178,"journal":{"name":"Progress in cardiovascular diseases","volume":" ","pages":""},"PeriodicalIF":7.6,"publicationDate":"2026-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149329253","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Residual physiological profiles in patients with CABG- or PCI-Favored coronary anatomy: A post hoc analysis of the PANDA III randomized clinical trial. CABG或pci有利冠状动脉解剖患者的残留生理特征:PANDA III随机临床试验的事后分析
IF 7.6
Progress in cardiovascular diseases Pub Date : 2026-11-02 DOI: 10.1016/j.pcad.2026.10.009
Kaibo Hu, Han Xu, Bowen Li, Haoyu Wang, Sheng Yuan, Shaoyu Wu, Changdong Guan, Chenxi Song, Guofeng Gao, Min Yang, Tao An, Zhiyong Zhao, Hao Wang, Yanyan Zhao, Weida Liu, Lei Jia, Qianqian Liu, Chunyue Wang, Chao Wu, Weihua Song, Hongjian Wang, Lei Song, Lei Feng, Chenggang Zhu, Dong Yin, Rui Zhang, Kefei Dou
{"title":"Residual physiological profiles in patients with CABG- or PCI-Favored coronary anatomy: A post hoc analysis of the PANDA III randomized clinical trial.","authors":"Kaibo Hu, Han Xu, Bowen Li, Haoyu Wang, Sheng Yuan, Shaoyu Wu, Changdong Guan, Chenxi Song, Guofeng Gao, Min Yang, Tao An, Zhiyong Zhao, Hao Wang, Yanyan Zhao, Weida Liu, Lei Jia, Qianqian Liu, Chunyue Wang, Chao Wu, Weihua Song, Hongjian Wang, Lei Song, Lei Feng, Chenggang Zhu, Dong Yin, Rui Zhang, Kefei Dou","doi":"10.1016/j.pcad.2026.10.009","DOIUrl":"https://doi.org/10.1016/j.pcad.2026.10.009","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background and aims: &lt;/strong&gt;Patients with anatomically complex coronary artery disease may be considered more suitable for coronary artery bypass grafting (CABG) than percutaneous coronary intervention (PCI), but some undergo PCI because of clinical constraints and experience higher long-term cardiovascular risk. The physiological rationale underlying this excess post-PCI risk remains unclear. From the perspective of post-PCI revascularization completeness and physiological results, we sought to explain the drivers of excess long-term adverse risk among patients with Favor CABG anatomy undergoing PCI.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;Coronary physiology based on quantitative flow ratio (QFR) was retrospectively evaluated in the randomized PANDA III trial in which all patients underwent PCI. Patients were stratified into 2 predefined groups by baseline SYNTAX score: Favor PCI or Favor CABG. Functional revascularization completeness was assessed using classic residual functional SYNTAX score (c-rFSS). Final physiological results were quantified by post-PCI QFR. Causal mediation analyses used 2-year major adverse cardiovascular events (MACE) excluding periprocedural MI as the outcome to estimate the proportion of the group-outcome association statistically accounted for by residual coronary physiological profiles. The primary endpoint was 2-year MACE, defined as the composite of all-cause death, all MI, or any ischemia-driven revascularization.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;A total of 1555 patients with complete post-PCI physiological assessment constituted the final study cohort, among whom 269 (17.3%) individuals were stratified to Favor CABG group by baseline SYNTAX score. The 2-year MACE rate was significantly higher in the Favor CABG than the Favor PCI group (18.6% vs 9.2%; adjusted HR: 1.78; 95% CI: 1.27-2.50). Functional incomplete revascularization (c-rFSS &gt;0) was substantially more prevalent among patients in the Favor CABG group (53.2% vs. 15.1%, P &lt; 0.001). Suboptimal post-PCI physiology defined by QFR &lt;0.90 was more frequent in Favor CABG cohort (32.0% vs 11.8%, P &lt; 0.001). In analyses using MACE excluding periprocedural MI, the estimated proportions mediated by functional incomplete revascularization and suboptimal post-PCI physiology were 49.4% and 47.8%, respectively, and their estimated joint proportion mediated was 79.8%. Integrating c-rFSS or post-PCI QFR into clinical-anatomic risk models significantly improved discrimination and reclassification capacity for 2-year MACE (all P &lt; 0.05).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;In this post hoc analysis of an all-comers PCI trial, approximately one-fifth of patients presented with anatomic complexity warranting CABG as the preferred revascularization strategy. Favor CABG anatomy was associated with higher 2-year MACE than Favor PCI anatomy. This association may be partly explained by the higher prevalence of residual functional incomplete revascularization and suboptimal p","PeriodicalId":94178,"journal":{"name":"Progress in cardiovascular diseases","volume":" ","pages":""},"PeriodicalIF":7.6,"publicationDate":"2026-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149329254","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Multidimensional profiling of serum biomarker nutritional scores in TAVR using principal component analysis. 利用主成分分析对TAVR患者血清生物标志物营养评分进行多维分析。
IF 7.6
Progress in cardiovascular diseases Pub Date : 2026-10-30 DOI: 10.1016/j.pcad.2026.10.013
Massimo Baudo, Serge Sicouri, Dimitrios E Magouliotis, Scott M Goldman, Khalid Ridwan, Eric M Gnall, William A Gray, Sandro Gelsomino, Basel Ramlawi
{"title":"Multidimensional profiling of serum biomarker nutritional scores in TAVR using principal component analysis.","authors":"Massimo Baudo, Serge Sicouri, Dimitrios E Magouliotis, Scott M Goldman, Khalid Ridwan, Eric M Gnall, William A Gray, Sandro Gelsomino, Basel Ramlawi","doi":"10.1016/j.pcad.2026.10.013","DOIUrl":"10.1016/j.pcad.2026.10.013","url":null,"abstract":"<p><strong>Background: </strong>Pre-procedural nutritional status has been proposed as a prognostic marker in transcatheter aortic valve replacement (TAVR), although most studies rely on isolated nutrition scores. This study examined how multiple serum-based nutritional scores influence post-TAVR survival.</p><p><strong>Methods: </strong>Consecutive patients undergoing TAVR between December 2021 and December 2023 were retrospectively analyzed. Eight serum biomarker-based scores were calculated for each patient (GNRI, PNI, CONUT, PALBI, TCBI, PACI, AGR, ALBI). Associations with overall survival were assessed with Kaplan-Meier curves and adjusted multivariable Cox regression. Principal component analysis (PCA) evaluated relationships among scores.</p><p><strong>Results: </strong>A total of 459 patients were included (mean age 81.7 ± 7.1 years, 45.8% female, median STS 2.8 [1.8-4.4]). The eight scores frequently classified the same patients into different risk strata. Significant survival differences were observed for all scores' most severe stratification except CONUT (p = 0.083) and PNI (p = 0.133). In adjusted Cox models, most scores showed a statistically significant association with overall mortality, except for GNRI (p = 0.237), PALBI (p = 0.378) and TCBI (p = 0.125). PCA demonstrated substantial collinearity among several scores and highlighted a dominant first principal component (PC), PC1 = 54%, without improved discrimination compared to STS score. In the adjusted Cox model, PC1 was also significantly associated with overall mortality (p < 0.001).</p><p><strong>Conclusions: </strong>Despite capturing overlapping biological domains, serum-based nutritional scores inconsistently classify TAVR patients. PCA suggests that a single underlying biomarker dimension explains most of the variability among scores, highlighting overlap and inconsistency across them and supporting the need for a more integrated approach to nutritional assessment rather than single metrics.</p>","PeriodicalId":94178,"journal":{"name":"Progress in cardiovascular diseases","volume":" ","pages":""},"PeriodicalIF":7.6,"publicationDate":"2026-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149303627","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书